CRS vs EFX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Carpenter Technology exhibits exceptional fundamental health with a Piotroski F-Score of 8/9 and a very conservative debt profile (D/E 0.35). However, the stock is severely overvalued from a deterministic standpoint, trading at $427.48—well above both its Graham Number ($87.77) and its growth-based Intrinsic Value ($253.41). While earnings growth is robust and analysts remain bullish, the combination of a bearish technical trend (10/100) and significant insider selling ($33.32M) suggests the current price has decoupled from fundamental value.
EFX presents a dichotomy between strong operational growth and deteriorating market sentiment. While the Piotroski F-Score of 6/9 indicates stable financial health and the company maintains impressive YoY earnings growth of 34%, the technical trend is severely bearish (0/100) with the stock trading near its 52-week low. The current price of $172.47 is closely aligned with the growth-based intrinsic value ($167.26) but significantly exceeds the defensive Graham Number ($69.68). Liquidity concerns are evident in the low current ratio (0.61), and aggressive insider selling by the CEO and other officers adds to the bearish outlook despite a 'Buy' analyst consensus.
Compare Another Pair
Related Comparisons
CRS vs EFX: Head-to-Head Comparison
This page compares Carpenter Technology Corporation (CRS) and Equifax Inc. (EFX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.